MEDIUM confidence: 95% data completeness, but the composite (50) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Not enough return history to estimate factor exposures — 9 of 36 months required. This stock is too recently listed (or has too short a price history) for a reliable Fama-French regression.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-12.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$861K over 180 days (0 open-market buys, 8 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $23.1B— | $29.3B+26.7% | $25.3B-13.8% | $26.7B+5.8% | $29.6B+10.6% |
| EPS (dil.) | $2.26— | $3.26+44.2% | $3.62+11.0% | $3.99+10.2% | $3.92-1.8% |
| Free Cash Flow | -$1.1B— | -$1.6Bn/m | -$1.5Bn/m | $833Mn/m | -$2.9B-452.3% |
| Gross Margin | 44.3% | 36.3%-8.0pp | 46.4%+10.1pp | 49.9%+3.6pp | 29.8%-20.1pp |
| Operating Margin | 16.0% | 18.3%+2.3pp | 23.1%+4.7pp | 26.4%+3.4pp | 24.6%-1.8pp |
| Net Margin | 10.4% | 12.1%+1.7pp | 15.7%+3.7pp | 16.5%+0.7pp | 14.7%-1.8pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $1.01 | $1.13 | +11.9% |
| Apr 2026 | $1.21 | $1.32 | +9.1% |
| Feb 2026 | $0.56 | $0.55 | -1.4% |
| Oct 2025 | $1.51 | $1.60 | +6.0% |
| Jul 2025 | $0.88 | $0.92 | +5.1% |
| May 2025 | $1.20 | $1.23 | +2.5% |
| Feb 2025 | $0.51 | $0.50 | -1.2% |
| Oct 2024 | $1.34 | $1.43 | +6.7% |
The QScore of 50 for SOMN suggests a neutral outlook, with the stock's long-term and short-term scores closely aligned. SOMN scores high on profitability, driven by its strong ROE of 12.6% and operating margin of 24.2%, but is held back by its value and growth scores, which are negatively impacted by its P/E of 22.5 and significant decline in free cash flow growth. The stock's momentum score is modestly positive, despite a recent 3-month decline of 0.8%, and its risk profile is relatively low due to a beta of 0.3.